You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Obesity

Setmelanotide for treating obesity caused by LEPR or POMC deficiency

  • Highly specialised technologies guidance
  • Reference number: HST21
  • Published:  06 July 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Information about setmelanotide
  • 3 Committee discussion
  • 4 Implementation
  • 5 Evaluation committee members and NICE project team
  • Update information

Update information

Minor changes since publication

March 2025: Links were updated following publication of NICE's guideline on overweight and obesity management.

ISBN: 978-1-4731-4614-3


Previous page 5 Evaluation committee members and NICE project team
Back to top